NuCana plc (NCNA)
NASDAQ·Healthcare·Biotechnology
$2.15
-2.94%
Mkt Cap $11.84M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 19, 2026 | — | — | — | -$2.69 | -$1.47 | +45.44% | — | — |
| Q4 2025 Nov 13, 2025 | — | — | — | -$2.69 | -$0.10 | +96.28% | — | — |
| Q3 2025 Aug 20, 2025 | — | — | — | -$2.75 | -$0.16 | +94.17% | — | — |
| Q2 2025 Jun 2, 2025 | — | — | — | -$2.58 | -$126.00 | -4778.05% | — | — |
| Q1 2025 Mar 20, 2025 | — | — | — | -$486.00 | -$64.00 | +86.83% | — | — |
| Q4 2024 Nov 25, 2024 | — | — | — | -$3.47 | -$456.00 | -13041.21% | — | — |
| Q3 2024 Aug 15, 2024 | — | — | — | -$710.00 | -$758.00 | -6.76% | — | — |
| Q2 2024 May 16, 2024 | — | — | — | -$662.00 | -$32.00 | +95.17% | — | — |
| Q1 2024 Mar 20, 2024 | — | — | — | -$650.00 | -$850.00 | -30.77% | — | — |
| Q4 2023 Nov 16, 2023 | — | — | — | -$650.00 | -$800.00 | -23.08% | — | — |
| Q3 2023 Aug 16, 2023 | — | — | — | -$800.00 | -$650.00 | +18.75% | — | — |
| Q2 2023 May 17, 2023 | — | — | — | -$600.00 | -$900.00 | -50.00% | — | — |
| Q2 2023 Apr 4, 2023 | — | — | — | — | -$0.07 | — | — | — |
| Q4 2022 Nov 16, 2022 | — | — | — | -$650.00 | -$550.00 | +15.38% | — | — |
| Q3 2022 Aug 17, 2022 | — | — | — | -$700.00 | -$450.00 | +35.71% | — | — |
| Q2 2022 Jun 2, 2022 | — | — | — | -$950.00 | -$1050.00 | -10.53% | — | — |
| Q2 2022 Apr 27, 2022 | — | — | — | — | -$0.14 | — | — | — |
| Q4 2021 Nov 18, 2021 | — | — | — | -$1250.00 | -$1050.00 | +16.00% | — | — |
| Q3 2021 Aug 19, 2021 | — | — | — | -$1200.00 | -$1200.00 | +0.00% | — | — |
| Q2 2021 May 19, 2021 | — | — | — | -$1100.00 | -$1300.00 | -18.18% | — | — |